A Study of Lispro Formulations in Healthy Participants
NCT02293551
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
Lispro
Sponsor
Eli Lilly and Company